Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"antisense therapy"”.
-
Optimization and personalization of antisense therapy for myotonic dystrophy type 1
… generations. Although there is no cure yet, antisense oligonucleotide (ASO) drugs that target the toxic RNA show most promise. This thesis tested two ASO strategies using nanoparticles, to improve drug delivery, and investigated how longer or shorter repetitions affect drug response. Results …
-
Studying the effect of OGX-225, a novel antisense therapy, on prostate cancer cells
… PCa cells. OGX-225 is a novel second- generation antisense drug (ASO) that targets both IGFBP-2 and IGFBP-5. M. Muramaki et al, at the prostate center in Vancouver, showed in their unpublished data that it inhibits the growth PCa cells both in vitro and in vivo, and that it downregulates IGFBP-2 …
-
Using synthetic oligonucleotides to modify cellular IRES structures and control gene expression
… viral infections and cancer. In this sense, antisense therapy could be of particular interest. Antisense therapy uses antisense oligonucleotides to control gene expression by inducing RNA degradation, changes in splicing or blocking the translation machinery. Since antisense therapy was …
-
Investigating antisense oligonucleotides for reducing ACTH production in an in vitro model of Cushing’s disease
… often accompanied by unpleasant side-effects. Antisense therapy is a technique for suppressing gene expression at the level of translation using antisense oligonucleotides (ASOs) against the mRNA of interest. Aims: Using an in vitro AtT-20 cell model, the overall aim of the project was to …
-
Requirements and strategies for winning the battle against antibiotic resistance by antisense technology
… and conditions for efficiency and specificity of antisense molecules. For specific therapy, an antibacterial RNA must be able to distinguish between its designed targets and its off-targets. This distinction is reflected in the binding energy calculations. The major component of efficiency and …
-
Gene therapy in spinal muscular atrophy : RNA-based strategies to modulate the pre-mRNA splicing of survival motor neuron
… by the development of bifunctional RNAs, antisense RNAs, and a multiple-antisense therapy targeting various regulator regions in and around the required exon. This work has shown the feasibility of multiple types of therapeutic RNA modalities in several assays both in vitro and in a …
-
Developing a Strategic Policy Choice Framework for Technological Innovation: Case of Chinese Pharmaceuticals
… technology, cell and tissue engineering, gene therapy, antisense therapy, RNAi, nanobiotechnology, synthetic biology, bioinformatics, pharmacogenetics, gene sequencing, and biotechnology diagnostics. For most of these technology areas, the results have indicated an imitative innovation strategy …
-
Biodegradable polymers for the sustained release of antisense nucleic acids
Antisense oligodeoxynucleotides can selectively inhibit individual gene expression provided they remain stable at the target site for a sufficient period of time. Thus, the efficacy of antisense oligodeoxynucleotides may be improved by employing a sustained release delivery system which would …
-
DNA chip designed antisense oligodeoxynucleotides targeting EGFR MRNA for brain tumour therapy
… 40% of GBM. Novel forms of treatment such as antisense therapy may allow for the specific inhibition of aberrant genes and thus they are optimistic therapies for future treatment of GBM. Oligodeoxynucleotides (ODNs) are small pieces of DNA that are often modified to increase their stability to …
-
Application of antisense oligonucleotides to prevent Candida albicans infections
… by the scarcity of new classes of fungal drugs. Antisense oligonucleotides (ASOs) can hold great promise as a therapeutic agent, however yet they are poorly explored for controlling Candida infections. Therefore, the main goal of this work was to develop a therapeutic approach based on antisense …
-
Cysteine Based PNA (CPNA): Design, Synthesis and Application
… history of the PNA as the front-runner of the antisense therapeutic agents. Chapter two discusses the novel protocols that enabled synthesis of the various versions of CPNA monomers for both Fmoc and Boc solid phase synthesis strategies. Chapter three includes the experimental procedures for …